Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
400 participants
OBSERVATIONAL
2023-03-30
2024-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of the Self-Care Support Program on Women With Endometriosis
NCT05861739
The Effect of Nursing Care Program on Women With Endometriosis
NCT05402943
Influence of an App on Quality of Life of Women With Endometriosis
NCT05528601
Effect of Yoga on Pelvic Pain and Quality of Life in Endometriosis
NCT07202741
Validation ( Endometriosis Health Profile) EHP-30 (Turkish Version) for Patients With Endometriosis
NCT03744377
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Scale development
Scale development
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with endometriosis,
* Having no medical or gynecological problems other than endometriosis,
* Able to read and write,
* Not pregnant,
* No barriers to communication,
* Not diagnosed with a psychiatric illness,
* Volunteer to participate in the study,
* Women who can speak and understand Turkish will be included.
* Followed for at least 6 months,
* Having symptoms related to endometriosis,
Exclusion Criteria
18 Years
49 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Marmara University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hamide Arslan Tarus
Maltepe, Istanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
52
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.